Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Health

Binovi Technologies appoints renowned educator Susan Barry to its Scientific Advisory Board

The company says Dr. Barry's work in the neurological examination of vision will be valuable in its pursuit of further testing and treatment options for students and patients

Binovi Technologies Corp (CVE:VISN) (OTCQB:BNVIF) Tuesday announced that it has appointed Susan Barry to the company’s Scientific Advisory Board.

Dr Barry is an educator, scientist, and author with an expertise in neuroplasticity and binocular vision, who has previously worked as a research neuroscientist at the University of Miami Medical School, the University of Michigan, the Marine Biological Laboratory, and NASA's Johnson Space Center.

Binovi Technologies CEO Adam Cegielski said in statement: "Dr Barry's experiences as a patient of vision therapy have informed her extensive career and we hope to gain from her perspective on both sides of the vision care coin. Her work in the neurological examination of vision will prove incredibly valuable in our pursuit of further testing and treatment options for students and patients young and old."

READ: Binovi welcomes Candian Olympic gold medalist Jennifer Botterill as a brand ambassador, performance advisory board member

Following the appointment, Dr Barry commented: "Children struggling in school, adults recovering from a stroke, and athletes seeking to improve their game may all benefit from vision therapy. Its effects are often life-changing. I am looking forward to working with the Binovi team to develop new training techniques, explore the science behind vision therapy, and make vision therapy more accessible worldwide."

Binovi Technologies is employing its neuro-visual performance platform, currently in use in more than 20 countries, to test, analyze, track, and report on individual cognitive results.

In August, the company announced plans to bring its vision therapy technology platform to North American classrooms, entering the K-12 education space. Students will use Binovi’s technology-driven vision training protocols to develop and strengthen literacy skills from pre-kindergarten to Grade 12 as part of the Toronto- and New York-based firm’s ‘Global and Noble’ initiative.

Binovi said it hopes to penetrate the nearly 145,000 schools across North America with its product offering, estimating that revenue per school would be approximately $50,000 to $100,000 based on a licensing product structure.

Contact Sean at sean@proactiveinvestors.com

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK